Institut Pasteur Korea

Last updated
Institut Pasteur Korea
Institut Pasteur Korea Bundang with some construction work.jpg
EstablishedApril 12, 2004
Chair Yong-Kyung Choe
CEOYoungmee Jee
Staff100 Pasteurians
Address 16, Daewangpangyo-ro 712beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea
Website www.ip-korea.org

Institut Pasteur Korea is an infectious disease-focused research institute located in Gyeonggi Province, Rep. of Korea. Its mission [1] is to identify novel molecular targets and discover small molecules by utilizing its proprietary platforms to diagnose, treat and address serious unmet global public health needs.

Contents

It was inaugurated as a nonprofit private research institute on 12 April 2004 [2] as a collaboration between the Institut Pasteur in Paris and Korea Institute of Science and Technology (KIST) in Seoul and it is supported by the Korean government through the Ministry of Science and ICT (former Ministry of Science and Technology) [3] and Gyeonggi Province.

Institut Pasteur Korea has been a key driver of early drug discovery among the 33 members of the Institut Pasteur International Network located in 25 countries on 5 continents, including China, Cambodia, Laos, Vietnam and Korea within Asia.

Institut Pasteur Korea is also focused on discovery biology to study and understand TB and on the development of new and more effective ways to diagnose and treat the disease. Institut Pasteur Korea also tackles COVID-19, Antimicrobial resistance, HCV, HBV, influenza, leishmaniasis, dengue fever and cancer.

The Institute is housed in a purpose-built facility in the city of Pangyo in Gyeonggi Province, 20 km south of Seoul.

Origins

Institut Pasteur Korea was established by collaboration between Institut Pasteur and KIST. [4] The Institut Pasteur is a private foundation dedicated to the study of biology, microorganisms, diseases and vaccines. It is named after Louis Pasteur, its founder and first director, who successfully developed the first anti-rabies serum in 1885. KIST, founded in 1966, was the first multi-disciplinary scientific research institute in Korea and has contributed significantly to the economic development of the country. [5]

In 2003, two major agreements between Institut Pasteur Paris and KIST paved the way for the launch of Institut Pasteur Korea. One established financial arrangements for the operation of the institute; the other was a general agreement on its foundation and management. Institut Pasteur Korea was mandated to expand the reach of Institut Pasteur by moving basic research toward therapy development and to introduce the “Pasteurian” research mission, management and culture to Korea. [3] Over its 130-year history, the Institut Pasteur in Paris has combined scientific achievements with their application in public health.

Institut Pasteur Korea was inaugurated in April 2004. Operations began at the start of 2005 under the motto “From Drug to Genes”, with the mission of turning basic research into pharmaceuticals using “target-free” drug discovery. Using this approach, drugs are sought in a cellular context, with no preconceived notions of what targets within the cell are relevant.

Institut Pasteur Korea joined the Institut Pasteur International Network in November 2004 as a private foundation recognized as working toward the public good through biomedical research.

Until April 2009, Institut Pasteur Korea was located in a small facility on the campus of KIST. It then moved into a new 15,199 square meter facility in Pangyo, Gyeonggi Province. The institute is one of the few in the world that contains robotic, high throughput optical imaging capacity within biosafety level 2 and 3 facilities.

Organization

Institut Pasteur Korea is organized into three divisions, Discovery Biology, Translation Research and Administration. These functional units collaborate across disciplines and classical research boundaries, providing an effective operational organization to meet the strategic goals of the institute.

Research and technology

Institut Pasteur Korea’s target identification technology uses high-content, genome-wide visual arrays to identify targets of interest in live cellular disease models. By screening with siRNA libraries, researchers can identify genes that alter drug sensitivity in the cellular disease model, thereby providing a way to quickly close in on the molecular targets.

Institut Pasteur Korea’s Discovery Chemistry group applies new concepts of drug design to optimize hit-to-lead identification. Its drug discovery technology platforms have led to the first-ever TB chemical screen performed using primary macrophages and resulting in a new best-in-class molecule to fight TB, referred to as Q203.

Financial support

Institut Pasteur Korea is funded through Korean government subsidies from the Ministry of Science and ICT, domestic and international grants, revenues from industry-sponsored research and license agreements, and donations.

Related Research Articles

<span class="mw-page-title-main">National Institute of General Medical Sciences</span> Medical research agency of the US Federal Government

The National Institute of General Medical Sciences (NIGMS) supports basic research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. NIGMS-funded scientists investigate how living systems work at a range of levels, from molecules and cells to tissues and organs, in research organisms, humans, and populations. Additionally, to ensure the vitality and continued productivity of the research enterprise, NIGMS provides leadership in training the next generation of scientists, in enhancing the diversity of the scientific workforce, and in developing research capacity throughout the country.

<span class="mw-page-title-main">Pasteur Institute</span> French disease research organization

The Pasteur Institute is a French non-profit private foundation dedicated to the study of biology, micro-organisms, diseases, and vaccines. It is named after Louis Pasteur, who invented pasteurization and vaccines for anthrax and rabies. The institute was founded on 4 June 1887 and inaugurated on 14 November 1888.

<span class="mw-page-title-main">Miguel Hernández University of Elche</span>

The Miguel Hernández University, is a Spanish Public University offering education, research and services facilitating the comprehensive development of its students. It is located in the province of Alicante and was established in 1996. Its name commemorates the Spanish poet Miguel Hernández.

<span class="mw-page-title-main">Korea Institute of Science and Technology</span> Multi-disciplinary research institute in Seoul, South Korea

The Korea Institute of Science and Technology is a multi-disciplinary research institute located in Seoul, South Korea. Founded in 1966, it was the first multi-disciplinary scientific research institute in Korea and has contributed significantly to the economic development of the country, particularly during the years of accelerated growth in the 1970s and 1980s. It has a research staff of over 1,800 research scientists, visiting scientists, fellows and trainees, and foreign scientists involved in basic research in various fields of science and technology.

<span class="mw-page-title-main">Korea Research Institute of Chemical Technology</span>

Korea Research Institute of Chemical Technology (KRICT) is the national chemical research institute for the Republic of Korea. It has performed research & development and public infrastructure services in chemistry and related convergence technologies. KRICT was established in 1976 and is a National Research Council of Science & Technology member. It is located at 141, Gajeong-ro, Yuseong-gu, Daejeon.

The Novartis Institute for Tropical Disease (NITD) was a Singapore-based tropical disease research institute created through a public-private partnership between Novartis and the Singapore Economic Development Board. Research at NITD focuses primarily on developing novel small molecule therapies for tropical infectious diseases that are endemic to the developing world, particularly dengue fever, malaria and tuberculosis.

<span class="mw-page-title-main">Philippe Sansonetti</span>

Philippe J. Sansonetti is a French microbiologist, professor at the Pasteur Institute and the Collège de France in Paris. He is the director of the Inserm Unit 786 and of the Institut Pasteur laboratory Pathogénie Microbienne Moléculaire.

Décrypthon is a project which uses grid computing resources to contribute to medical research. The word is a portmanteau of the French word "décrypter" and "telethon".

<span class="mw-page-title-main">André Choulika</span>

André Choulika is a biotechnologist, the inventor of nuclease-based genome editing and a pioneer in the analysis and use of meganucleases to modify complex genomes.

Sir Stewart Thomas Cole is a British/French microbiologist. He was the Director General of the Pasteur Institute since January 2018 to December 2023.

Chetan Eknath Chitnis is an Indian scientist in the field of malaria research. He is the head of the Malaria Parasite Biology and Vaccines Unit at the Institut Pasteur in Paris and an elected fellow of the Indian Academy of Sciences (2009) as well as Indian National Science Academy (2014). He received the Shanti Swaroop Bhatnagar Award in 2004 and the Infosys Prize in Life Sciences 2010. Chitnis is the former principal investigator of the malaria research group at the International Centre for Genetic Engineering and Biotechnology (ICGEB) in New Delhi.

Phenotypic screening is a type of screening used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell or an organism in a desired manner. Phenotypic screening must be followed up with identification and validation, often through the use of chemoproteomics, to identify the mechanisms through which a phenotypic hit works.

<span class="mw-page-title-main">Pangyo Techno Valley</span> Place in Seongnam, South Korea

Pangyo Techno Valley (PTV) is an industrial complex in the city of Pangyo, Seongnam, Gyeonggi Province, South Korea. It is also known as the Silicon Valley of Korea. The complex focuses on information technology, biotech, cultural technology and fusion technology. One of the benefits of the diversity of fields and businesses is the maximized growth potential in the field of high-tech technology through exchanges between the companies. The location within a major metropolitan area creates synergy effects because of the proximity to other techno valleys or adjacent knowledge-based infrastructure clusters in the province. The business environment of the PTV is supported by the government of the Gyeonggi Province through the implementation of various support facilities as for examples a R&D center or public support center.

<span class="mw-page-title-main">Hee-Sup Shin</span> South Korean neuroscientist (born 1950)

Hee-sup Shin is a South Korean neuroscientist whose work focuses on brain research of genetically engineered mice via gene knockout in order to better understand the human brain. His research resulted in him being named a National Scientist by the Korean Ministry of Science and Technology. He is a former co-director of the Center for Cognition and Sociality leading the Social Neuroscience Group in the Institute for Basic Science (IBS) located at Korea Advanced Institute of Science and Technology (KAIST).

<span class="mw-page-title-main">Ministry of Science, ICT and Future Planning</span>

The Ministry of Science, ICT and Future Planning was a ministry of the Government of South Korea. Its purpose is to set, manage, and evaluate science and technology policy, support scientific research and development, develop human resources, conduct R&D leading to the production and consumption of Atomic power, plan national informatization and information protection strategies, manage radio frequency bands, oversee the information and communications technology (ICT) industry, and operate Korea Post. Its headquarters we in Building #4 of the Gwacheon Government Complex in Gwacheon, Gyeonggi Province.

Open Source Drug Discovery is a Council of Scientific and Industrial Research, India (CSIR)-led Team India Consortium with global participation offering a collaborative drug discovery platform for neglected tropical diseases like leishmaniasis, which draw limited attention of research-based pharmaceutical enterprises. This program has a global community with over 7500 participants from 130 countries comprising researchers, academia, students, industries, educational institutions and so on. Anyone who is committed to the discovery of drugs for neglected diseases in an open source mode can participate in the program. OSDD functions by bringing together experts from diverse backgrounds to focus on discovering and developing affordable drugs for tropical infections.

Craig M. Crews is an American scientist at Yale University known for his contributions to chemical biology. He is known for his contributions to the field of induced proximity through his work in creating heterobifunctional molecules that "hijack" cellular processes by inducing the interaction of two proteins inside a living cell. His initial work focused on the discovery of PROteolysis-TArgeting Chimeras (PROTACs) to trigger degradation of disease-causing proteins, a process known as targeted protein degradation (TPD), and he has since developed new versions of -TACs to leverage other cellular processes and protein families to treat disease.

<span class="mw-page-title-main">Nevan Krogan</span> Canadian molecular and systems biologist

Nevan J. Krogan is a Canadian molecular and systems biologist. He is a professor and the Director of the Quantitative Biosciences Institute (QBI) at the University of California San Francisco (UCSF), as well as a senior investigator at the J. David Gladstone Institutes.

Choong Eui Song is a South Korean organic chemist.

<span class="mw-page-title-main">Suh Pann-Ghill</span> South Korean neuroscientist (born 1952)

Suh Pann-Ghill is a South Korean neuroscientist. He has served as a professor and vice president for research at UNIST and the third president of the Korea Brain Research Institute.

References

  1. Official website of Institut Pasteur Korea. Retrieved 7 October 2010. Archived 4 December 2010 at the Wayback Machine
  2. “Conclusion on General Agreement for Establishment of Institut Pasteur Korea” KIST Newsletter No. 294, January 26, 2004
  3. 1 2 Jae-Eun Lee, Gi-jung Chun, "The Key Success Factors of the Policy Implementation for the Government Innovation: Inducing Policy of the French Institute Pasteur", Korean Policy Sciences Review, Vol. 8, Nov.4 (December 2004)
  4. Creation of the Institut Pasteur of Korea Archived February 29, 2012, at the Wayback Machine
  5. Moo-Young Han, "Annotated Chronology of Korea's Science and Technology: From Rice Paddies to Flat Panel Displays" "KST". Archived from the original on June 5, 2011. Retrieved 2010-06-19.